Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal Metastasis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This is a prospective, multicenter, randomized controlled, open-label investigator-initiated clinical study to evaluate the clinical efficacy and quality of life of intrathecal chemotherapy through Ommaya reservoir in combination with systematic chemotherapy versus systemic chemotherapy alone in patients with Her-2 negative breast cancer with leptomeningeal metastasis.
Epistemonikos ID: 2b25fb7214a57489fae54bb8fd32ca77cbcf1179
First added on: May 15, 2024